Concepts and challenges of biosimilars to mitigate the oncology drug expenses
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
Yazar: | Tania, Umme |
---|---|
Diğer Yazarlar: | Haque , Md. Aminul |
Materyal Türü: | Tez |
Dil: | en_US |
Baskı/Yayın Bilgisi: |
Brac University
2021
|
Konular: | |
Online Erişim: | http://hdl.handle.net/10361/15111 |
Benzer Materyaller
-
Biosimilar in lymphoma treatment
Yazar:: Tanisha, Mehrin Haque
Baskı/Yayın Bilgisi: (2021) -
Biosimilar insulins: a potential option in the treatment of Diabetes
Yazar:: Tabassum, Turana
Baskı/Yayın Bilgisi: (2022) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
Yazar:: Tania, Umme
Baskı/Yayın Bilgisi: (2023) -
Advancement of Antibody-Drug conjugates in cancer treatment: A review
Yazar:: Sagar, Baejid Hossain
Baskı/Yayın Bilgisi: (2022) -
Immunotherapeutic approaches to treat cancer: Prospects and challenges
Yazar:: Fred, Namanda Rogers
Baskı/Yayın Bilgisi: (2021)